HEMATOLOGICAL MALIGNANCY
Clinical trials for HEMATOLOGICAL MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGICAL MALIGNANCY trials appear
Sign up with your email to follow new studies for HEMATOLOGICAL MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Bleeding breakthrough fizzles: fibrinogen trial for chemo patients halted after just one patient
Disease control TerminatedThis study tested a single injection of fibrinogen concentrate followed by a platelet transfusion in blood cancer patients with severe bleeding who did not respond to standard platelet transfusions. The goal was to see if it improved blood clotting. However, the trial was termina…
Matched conditions: HEMATOLOGICAL MALIGNANCY
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Liver impairment study for cancer drug tazemetostat halted early
Knowledge-focused TerminatedThis study looked at how the cancer drug tazemetostat is processed in the body of people with advanced solid tumors who also have moderate or severe liver impairment. Researchers compared drug levels in these patients to those with normal liver function. The trial was terminated …
Matched conditions: HEMATOLOGICAL MALIGNANCY
Phase: PHASE1 • Sponsor: Epizyme, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC